Clinical Trials Logo

Clinical Trial Summary

The aim of study is to investigate the effect of virtual reality application on balance and gait speed in individuals with Alzheimer's Dementia.


Clinical Trial Description

The aim of study is to investigate the effect of virtual reality application on balance and gait speed in individuals with Alzheimer's Dementia. The study consisted of 32 subjects, which were diagnosed as mild or moderate AD by the neurologist. The balance, fall risks and gait speed were assessed. Training group was trained with games selected from different categories such as balance and aerobic exercises with Nintendo Wii virtual reality device for 6 weeks, 1 session 30 min, 2 times a week. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03928405
Study type Interventional
Source Kirikkale University
Contact
Status Completed
Phase N/A
Start date January 1, 2018
Completion date June 6, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02959502 - Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression N/A
Completed NCT02759887 - Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD) N/A
Completed NCT01002586 - Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia N/A
Terminated NCT02804789 - European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
Completed NCT02190084 - Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia Phase 4
Completed NCT01409564 - Cilostazol Augmentation Study in Dementia Phase 4
Completed NCT01608217 - Delta-THC in Dementia Phase 2
Completed NCT04748263 - Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
Recruiting NCT01195389 - Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease N/A
Completed NCT01585272 - Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia Phase 4
Withdrawn NCT04812769 - Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases N/A